Rajash Pallai

Title: Rajash Pallai: Innovator in Cancer Treatment

Introduction

Rajash Pallai is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of targeted therapies. His work focuses on utilizing small interfering RNA (siRNA) to inhibit specific gene expressions associated with cancer progression.

Latest Patents

Rajash Pallai holds a patent for "SiRNA targeting ETS1 and ELK1 and method of using same in the inhibition of CIP2A gene in cancer treatment." This patent discloses methods for attenuating the activity of the gene promoter of CIP2A. The siRNAs are designed to target Ets1 and Elk1 transcriptional factors, effectively blocking their binding to the CIP2A gene promoter. The invention reveals that these targeted siRNAs can significantly reduce the expression of the CIP2A gene, which is crucial in cancer treatment. Additionally, a kit containing siRNA reagents for attenuating CIP2A gene expression is also included in the patent.

Career Highlights

Rajash Pallai is currently associated with Medical Diagnostic Laboratories, LLC, where he continues to advance his research in medical diagnostics and therapeutic innovations. His work has the potential to impact cancer treatment significantly, providing new avenues for therapy.

Collaborations

Rajash collaborates with various professionals in his field, including his coworker Lyndi Rice. Their combined expertise contributes to the development of innovative solutions in cancer research and treatment.

Conclusion

Rajash Pallai's contributions to cancer treatment through his patented innovations highlight the importance of targeted therapies in modern medicine. His work exemplifies the potential of siRNA technology in combating cancer and improving patient outcomes.